New hope for bulging eyes: drug trial targets thyroid eye disease
NCT ID NCT07462130
First seen Mar 30, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study tests a new drug called NTB003 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. The trial will include 74 adults aged 18-75 with active disease. Researchers will check if the drug safely reduces eye bulging and other symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.